report cover

Global Recombinant Antibody Market Research Report 2024(Status and Outlook)

  • 07 August 2024
  • Life Sciences
  • 108 Pages
  • Report code : 24WT-7982237

Recombinant Antibody Market

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Recombinant Antibody
1.2 Key Market Segments
1.2.1 Recombinant Antibody Segment by Type
1.2.2 Recombinant Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Recombinant Antibody Market Overview
2.1 Global Market Overview
2.1.1 Global Recombinant Antibody Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Recombinant Antibody Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Recombinant Antibody Market Competitive Landscape
3.1 Global Recombinant Antibody Sales by Manufacturers (2019-2024)
3.2 Global Recombinant Antibody Revenue Market Share by Manufacturers (2019-2024)
3.3 Recombinant Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Recombinant Antibody Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Recombinant Antibody Sales Sites, Area Served, Product Type
3.6 Recombinant Antibody Market Competitive Situation and Trends
3.6.1 Recombinant Antibody Market Concentration Rate
3.6.2 Global 5 and 10 Largest Recombinant Antibody Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Recombinant Antibody Industry Chain Analysis
4.1 Recombinant Antibody Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Recombinant Antibody Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Recombinant Antibody Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant Antibody Sales Market Share by Type (2019-2024)
6.3 Global Recombinant Antibody Market Size Market Share by Type (2019-2024)
6.4 Global Recombinant Antibody Price by Type (2019-2024)
7 Recombinant Antibody Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant Antibody Market Sales by Application (2019-2024)
7.3 Global Recombinant Antibody Market Size (M USD) by Application (2019-2024)
7.4 Global Recombinant Antibody Sales Growth Rate by Application (2019-2024)
8 Recombinant Antibody Market Segmentation by Region
8.1 Global Recombinant Antibody Sales by Region
8.1.1 Global Recombinant Antibody Sales by Region
8.1.2 Global Recombinant Antibody Sales Market Share by Region
8.2 North America
8.2.1 North America Recombinant Antibody Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Recombinant Antibody Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant Antibody Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Recombinant Antibody Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Recombinant Antibody Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abnova
9.1.1 Abnova Recombinant Antibody Basic Information
9.1.2 Abnova Recombinant Antibody Product Overview
9.1.3 Abnova Recombinant Antibody Product Market Performance
9.1.4 Abnova Business Overview
9.1.5 Abnova Recombinant Antibody SWOT Analysis
9.1.6 Abnova Recent Developments
9.2 Medix Biochemica
9.2.1 Medix Biochemica Recombinant Antibody Basic Information
9.2.2 Medix Biochemica Recombinant Antibody Product Overview
9.2.3 Medix Biochemica Recombinant Antibody Product Market Performance
9.2.4 Medix Biochemica Business Overview
9.2.5 Medix Biochemica Recombinant Antibody SWOT Analysis
9.2.6 Medix Biochemica Recent Developments
9.3 GE Healthcare
9.3.1 GE Healthcare Recombinant Antibody Basic Information
9.3.2 GE Healthcare Recombinant Antibody Product Overview
9.3.3 GE Healthcare Recombinant Antibody Product Market Performance
9.3.4 GE Healthcare Recombinant Antibody SWOT Analysis
9.3.5 GE Healthcare Business Overview
9.3.6 GE Healthcare Recent Developments
9.4 SinoBiological
9.4.1 SinoBiological Recombinant Antibody Basic Information
9.4.2 SinoBiological Recombinant Antibody Product Overview
9.4.3 SinoBiological Recombinant Antibody Product Market Performance
9.4.4 SinoBiological Business Overview
9.4.5 SinoBiological Recent Developments
9.5 Bioventix
9.5.1 Bioventix Recombinant Antibody Basic Information
9.5.2 Bioventix Recombinant Antibody Product Overview
9.5.3 Bioventix Recombinant Antibody Product Market Performance
9.5.4 Bioventix Business Overview
9.5.5 Bioventix Recent Developments
10 Recombinant Antibody Market Forecast by Region
10.1 Global Recombinant Antibody Market Size Forecast
10.2 Global Recombinant Antibody Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Recombinant Antibody Market Size Forecast by Country
10.2.3 Asia Pacific Recombinant Antibody Market Size Forecast by Region
10.2.4 South America Recombinant Antibody Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Recombinant Antibody by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Recombinant Antibody Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Recombinant Antibody by Type (2025-2030)
11.1.2 Global Recombinant Antibody Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Recombinant Antibody by Type (2025-2030)
11.2 Global Recombinant Antibody Market Forecast by Application (2025-2030)
11.2.1 Global Recombinant Antibody Sales (K Units) Forecast by Application
11.2.2 Global Recombinant Antibody Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant Antibody Market Size Comparison by Region (M USD)
Table 5. Global Recombinant Antibody Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Recombinant Antibody Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Recombinant Antibody Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Recombinant Antibody Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody as of 2022)
Table 10. Global Market Recombinant Antibody Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Recombinant Antibody Sales Sites and Area Served
Table 12. Manufacturers Recombinant Antibody Product Type
Table 13. Global Recombinant Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Recombinant Antibody
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Recombinant Antibody Market Challenges
Table 22. Global Recombinant Antibody Sales by Type (K Units)
Table 23. Global Recombinant Antibody Market Size by Type (M USD)
Table 24. Global Recombinant Antibody Sales (K Units) by Type (2019-2024)
Table 25. Global Recombinant Antibody Sales Market Share by Type (2019-2024)
Table 26. Global Recombinant Antibody Market Size (M USD) by Type (2019-2024)
Table 27. Global Recombinant Antibody Market Size Share by Type (2019-2024)
Table 28. Global Recombinant Antibody Price (USD/Unit) by Type (2019-2024)
Table 29. Global Recombinant Antibody Sales (K Units) by Application
Table 30. Global Recombinant Antibody Market Size by Application
Table 31. Global Recombinant Antibody Sales by Application (2019-2024) & (K Units)
Table 32. Global Recombinant Antibody Sales Market Share by Application (2019-2024)
Table 33. Global Recombinant Antibody Sales by Application (2019-2024) & (M USD)
Table 34. Global Recombinant Antibody Market Share by Application (2019-2024)
Table 35. Global Recombinant Antibody Sales Growth Rate by Application (2019-2024)
Table 36. Global Recombinant Antibody Sales by Region (2019-2024) & (K Units)
Table 37. Global Recombinant Antibody Sales Market Share by Region (2019-2024)
Table 38. North America Recombinant Antibody Sales by Country (2019-2024) & (K Units)
Table 39. Europe Recombinant Antibody Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Recombinant Antibody Sales by Region (2019-2024) & (K Units)
Table 41. South America Recombinant Antibody Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Recombinant Antibody Sales by Region (2019-2024) & (K Units)
Table 43. Abnova Recombinant Antibody Basic Information
Table 44. Abnova Recombinant Antibody Product Overview
Table 45. Abnova Recombinant Antibody Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abnova Business Overview
Table 47. Abnova Recombinant Antibody SWOT Analysis
Table 48. Abnova Recent Developments
Table 49. Medix Biochemica Recombinant Antibody Basic Information
Table 50. Medix Biochemica Recombinant Antibody Product Overview
Table 51. Medix Biochemica Recombinant Antibody Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Medix Biochemica Business Overview
Table 53. Medix Biochemica Recombinant Antibody SWOT Analysis
Table 54. Medix Biochemica Recent Developments
Table 55. GE Healthcare Recombinant Antibody Basic Information
Table 56. GE Healthcare Recombinant Antibody Product Overview
Table 57. GE Healthcare Recombinant Antibody Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. GE Healthcare Recombinant Antibody SWOT Analysis
Table 59. GE Healthcare Business Overview
Table 60. GE Healthcare Recent Developments
Table 61. SinoBiological Recombinant Antibody Basic Information
Table 62. SinoBiological Recombinant Antibody Product Overview
Table 63. SinoBiological Recombinant Antibody Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. SinoBiological Business Overview
Table 65. SinoBiological Recent Developments
Table 66. Bioventix Recombinant Antibody Basic Information
Table 67. Bioventix Recombinant Antibody Product Overview
Table 68. Bioventix Recombinant Antibody Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bioventix Business Overview
Table 70. Bioventix Recent Developments
Table 71. Global Recombinant Antibody Sales Forecast by Region (2025-2030) & (K Units)
Table 72. Global Recombinant Antibody Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Recombinant Antibody Sales Forecast by Country (2025-2030) & (K Units)
Table 74. North America Recombinant Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Recombinant Antibody Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Europe Recombinant Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Recombinant Antibody Sales Forecast by Region (2025-2030) & (K Units)
Table 78. Asia Pacific Recombinant Antibody Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Recombinant Antibody Sales Forecast by Country (2025-2030) & (K Units)
Table 80. South America Recombinant Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Recombinant Antibody Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Recombinant Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Recombinant Antibody Sales Forecast by Type (2025-2030) & (K Units)
Table 84. Global Recombinant Antibody Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Recombinant Antibody Price Forecast by Type (2025-2030) & (USD/Unit)
Table 86. Global Recombinant Antibody Sales (K Units) Forecast by Application (2025-2030)
Table 87. Global Recombinant Antibody Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Recombinant Antibody
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant Antibody Market Size (M USD), 2019-2030
Figure 5. Global Recombinant Antibody Market Size (M USD) (2019-2030)
Figure 6. Global Recombinant Antibody Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant Antibody Market Size by Country (M USD)
Figure 11. Recombinant Antibody Sales Share by Manufacturers in 2023
Figure 12. Global Recombinant Antibody Revenue Share by Manufacturers in 2023
Figure 13. Recombinant Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Recombinant Antibody Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Recombinant Antibody Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Recombinant Antibody Market Share by Type
Figure 18. Sales Market Share of Recombinant Antibody by Type (2019-2024)
Figure 19. Sales Market Share of Recombinant Antibody by Type in 2023
Figure 20. Market Size Share of Recombinant Antibody by Type (2019-2024)
Figure 21. Market Size Market Share of Recombinant Antibody by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Recombinant Antibody Market Share by Application
Figure 24. Global Recombinant Antibody Sales Market Share by Application (2019-2024)
Figure 25. Global Recombinant Antibody Sales Market Share by Application in 2023
Figure 26. Global Recombinant Antibody Market Share by Application (2019-2024)
Figure 27. Global Recombinant Antibody Market Share by Application in 2023
Figure 28. Global Recombinant Antibody Sales Growth Rate by Application (2019-2024)
Figure 29. Global Recombinant Antibody Sales Market Share by Region (2019-2024)
Figure 30. North America Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Recombinant Antibody Sales Market Share by Country in 2023
Figure 32. U.S. Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Recombinant Antibody Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Recombinant Antibody Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Recombinant Antibody Sales Market Share by Country in 2023
Figure 37. Germany Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Recombinant Antibody Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Recombinant Antibody Sales Market Share by Region in 2023
Figure 44. China Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Recombinant Antibody Sales and Growth Rate (K Units)
Figure 50. South America Recombinant Antibody Sales Market Share by Country in 2023
Figure 51. Brazil Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Recombinant Antibody Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Recombinant Antibody Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Recombinant Antibody Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Recombinant Antibody Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Recombinant Antibody Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Recombinant Antibody Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Recombinant Antibody Market Share Forecast by Type (2025-2030)
Figure 65. Global Recombinant Antibody Sales Forecast by Application (2025-2030)
Figure 66. Global Recombinant Antibody Market Share Forecast by Application (2025-2030)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Recombinant Antibody Market

Leave This Empty: